| Clinical data | |
|---|---|
| Other names | CD-2314; CD 2314 |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C23H24O2S |
| Molar mass | 364.50 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
CD2314 is a drug which acts as a retinoic acid receptor β (RARβ) agonist. It is used for research into the function of RARβ and promotes nerve repair following injury.